Home/ Crypto News/ Novo Nordisk (NVO) Stock Drops 15% as Company Unveils ‘Novo’ Rebrand Amid Obesity Drug Battle

blockonomi 4 days ago

Novo Nordisk (NVO) Stock Drops 15% as Company Unveils ‘Novo’ Rebrand Amid Obesity Drug Battle

Stocks

Novo Nordisk (NVO) stock tumbles 15% in 2026 as the pharma giant rebrands to 'Novo' and faces mounting competition from Eli Lilly in obesity drugs.

The post Novo Nordisk (NVO) Stock Drops 15% as Company Unveils ‘Novo’ Rebrand Amid Obesity Drug Battle appeared first on Blockonomi.

Source: Source: Blockonomi